Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric carboxymaltose in cardiac surgery
NCT03574311Phase 4Unknown
- Sponsor
- Turku University Hospital
- Start
- Oct 2018
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative complications comparing Ferric carboxymaltose with Placebo (2 arms). Primary endpoint: Incidence of allogeneic blood transfusion and/or nosocomial infection at 90 days. Status: unknown.
02
Drugs
ferric carboxymaltose
03
Conditions
postoperative complications
Beyond the preview
Go deeper on NCT03574311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03574311.